Target intelligence / Profile preview

DNA synthesis or mitosis machinery

Molecular classification
Other (as a group: includes Enzyme, Structural protein, Other)
01

Overview

“DNA synthesis or mitosis machinery” describes the collective set of proteins and macromolecular complexes required for accurate DNA replication (S phase) and subsequent chromosome segregation during mitosis. For DNA synthesis, key components include DNA polymerases, helicases, primases, topoisomerases, ligases, and single-strand DNA-binding proteins, which together form the replication fork and replisome complexes[1][2][6][7]. For mitosis, the machinery encompasses the structures and proteins that build and regulate the mitotic spindle (e.g., tubulins, centrosomes, microtubule-associated proteins), kinetochores, cohesins, and regulatory proteins such as cyclin-dependent kinases[3][4][5]. Aberrant function of these complexes is critical in cancer and other proliferative diseases, making individual components (but not the entire "machinery" as a unit) key targets for anticancer chemotherapy. The designation "DNA synthesis or mitosis machinery" is overly broad and does not correspond to a single gene, protein, or canonical drug target, but rather to a system of interacting components that are targeted individually in therapy.

Other names
DNA replication machineryDNA synthesis enzymesmitotic machineryreplisomemitotic spindle apparatus
02

Mechanism of action

Inhibition of DNA polymerase activity; Inhibition of topoisomerase-mediated DNA winding/unwinding; Disruption of microtubule polymerization/depolymerization; Inhibition of cell cycle regulators (e.g., CDKs); Interference with mitotic spindle function

03

Biological functions

Cell cycleDNA replicationChromosome segregationCell divisionGenome stabilityChromatin regulation
04

Disease associations

CancerGenomic instability syndromesDevelopmental disorders
05

Safety considerations

MyelosuppressionMucositisAlopeciaGastrointestinal toxicityNeurotoxicity (for microtubule-targeting agents)Genotoxicity
06

Interacting drugs

Antimetabolites (e.g., cytarabine, gemcitabine)

4 more in the full profile.

07

Biomarkers

Proliferation markers (e.g., Ki-67, PCNA)Phosphorylated histone H3Cyclin levelsMitotic index

Beyond the preview

Go deeper on DNA synthesis or mitosis machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA synthesis or mitosis machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call